TC011
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TC011, covering 2026-01-22 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients [Phase 1, Phase 2]